NeoGenomics, Inc.

NeoGenomics, Inc. financial statements

NeoGenomics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 727.33M10-K
Net income−USD 108.03M10-K
Cash and equivalentsUSD 159.62M10-Q
Total debtUSD 341.86M10-K

NeoGenomics, Inc. financials on 6ix · NeoGenomics, Inc. on 6ix